rs540169523
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2
The NM_001098.3(ACO2):c.1550C>T(p.Thr517Met) variant causes a missense change. The variant allele was found at a frequency of 0.000144 in 1,614,166 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001098.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000290 AC: 73AN: 251480Hom.: 0 AF XY: 0.000434 AC XY: 59AN XY: 135918
GnomAD4 exome AF: 0.000150 AC: 219AN: 1461864Hom.: 4 Cov.: 32 AF XY: 0.000216 AC XY: 157AN XY: 727232
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74482
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
The ACO2 p.Thr517Met variant was not identified in the literature but was identified in dbSNP (ID: rs540169523) and ClinVar (classified as uncertain significance by Genomic Research Center, Shahid Beheshti University of Medical Sciences). The variant was identified in control databases in 74 of 282884 chromosomes at a frequency of 0.0002616 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 71 of 30616 chromosomes (freq: 0.002319), Other in 2 of 7224 chromosomes (freq: 0.000277) and European (non-Finnish) in 1 of 129182 chromosomes (freq: 0.000008), but was not observed in the African, Latino, Ashkenazi Jewish, East Asian, or European (Finnish) populations. The p.Thr517 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Infantile cerebellar-retinal degeneration Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at